First report on the reliability and validity of speech handicap index in native English-speaking patients with head and neck cancer
Autor: | Rehan Kazi, Behrad Elmiyeh, Edward J. Chisholm, Cyrus Kerawala, Suzanne St. Rose, Christopher M. Nutting, Raghav C. Dwivedi, Peter Rhys-Evans, Kevin J. Harrington, Peter Clarke, Justin W. G. Roe |
---|---|
Rok vydání: | 2010 |
Předmět: |
Adult
Male medicine.medical_specialty Dentistry Comorbidity Severity of Illness Index Speech Disorders Cohort Studies Disability Evaluation Age Distribution Quality of life Cronbach's alpha Surveys and Questionnaires medicine Humans Disabled Persons Sex Distribution Aged Language Aged 80 and over Mouth neoplasm business.industry Incidence fungi Head and neck cancer Reproducibility of Results Cancer Construct validity Middle Aged medicine.disease Causality Oropharyngeal Neoplasms Otorhinolaryngology Head and Neck Neoplasms Quality of Life Physical therapy Female Mouth Neoplasms business Follow-Up Studies Cohort study |
Zdroj: | Head & Neck. |
ISSN: | 1097-0347 1043-3074 |
DOI: | 10.1002/hed.21450 |
Popis: | Background. Posttreatment speech problems are seen in nearly half of patients with head and neck cancer. Although there are many voice-specific scales, surprisingly there is no speech-specific questionnaire for English-speaking patients with head and neck cancer. The aim of this study was to validate the Speech Handicap Index (SHI) as the first speech-specific questionnaire in the English language. Method. In all, 55 consecutive patients in follow-up for oral and oropharyngeal cancer completed the SHI and University of Washington Quality of Life Questionnaire (UWQOL V.04). Thirty-two patients completed both questionnaires again 4 weeks later to address test-retest reliability. Results. Internal consistency, test-retest reliability, construct validity, and group validity of the SHI were found to be highly significant (p < .01) using Cronbach's alpha, Spearman's correlation coefficient (r), and Mann-Whitney U tests. Conclusions. The SHI is a precise, highly reliable, and valid speech assessment tool for patients with head and neck cancer. Further dedicated studies using the SHI in patients with head and neck cancer would be useful. (C) 2010 Wiley Periodicals, Inc. Head Neck 33: 341-348, 2011 |
Databáze: | OpenAIRE |
Externí odkaz: |